Daoui S, Cui Y Y, Lagente V, Emonds-Alt X, Advenier C
Laboratoire de Pharmacologie, Faculté de Médecine Paris-Ouest, France.
Pulm Pharmacol Ther. 1997 Oct-Dec;10(5-6):261-70. doi: 10.1006/pupt.1998.0104.
Aerosolized substance P (0.1 M, for 30 min) induced airway hyperresponsiveness in guinea-pigs 24 h after they were pre-treated with salbutamol (8.7 mM by aerosol for 10 min) and phosphoramidon (0.1 mM by aerosol for 10 min). This was displayed by an exaggerated response to the bronchoconstrictor effect of acetylcholine. A microvascular leakage hypersensitivity also occurred and was demonstrated by a potentiation of the plasma protein extravasation from bronchial vessels induced by histamine. The aim of this study was to investigate the effects of the non-peptide and potent tachykinin NK3 receptor antagonist, SR 142801 (osanetant), in comparison with those of the tachykinin NK1 and NK2 receptor antagonists, SR 140333 (nolpitantium) and SR 48968 (saredutant) respectively, on substance P. When given once at 1 mg/kg i.p. 45 min before exposure to substance P, SR 142801 prevented both hyperresponsiveness to acetylcholine and the potentiation of histamine-induced increase in microvascular permeability. SR 142801 did not exhibit any tachykinin NK1 or NK2 antagonistic activity in experiments on guinea-pig isolated airways, in vitro or in vivo. The results suggest that tachykinin NK3 receptors might be involved in these substance P-induced effects on airways.
雾化给予P物质(0.1 M,持续30分钟)可在豚鼠预先用沙丁胺醇(8.7 mM雾化10分钟)和磷酰胺(0.1 mM雾化10分钟)处理24小时后诱导气道高反应性。这表现为对乙酰胆碱支气管收缩作用的过度反应。还出现了微血管渗漏超敏反应,这通过组胺诱导的支气管血管血浆蛋白外渗增强得以证明。本研究的目的是比较非肽类强效速激肽NK3受体拮抗剂SR 142801(奥沙奈坦)与速激肽NK1和NK2受体拮抗剂SR 140333(诺匹坦)和SR 48968(沙瑞肽坦)分别对P物质的影响。在暴露于P物质前45分钟腹腔注射1 mg/kg的SR 142801,可预防对乙酰胆碱的高反应性以及组胺诱导的微血管通透性增加的增强。在豚鼠离体气道的体外或体内实验中,SR 142801未表现出任何速激肽NK1或NK2拮抗活性。结果表明,速激肽NK3受体可能参与了这些P物质诱导的气道效应。